Daniel K. Ebner, M.D., M.P.H.

Daniel Keith Ebner, M.D., M.P.H., is a senior associate consultant in the Department of Radiation Oncology at Mayo Clinic in Rochester, Minnesota. Dr. Ebner provides advanced radiation treatment options for people with cancer in Rochester and surrounding areas, specializing in precision therapies that combine technology and human-centered care. His clinical focus includes carbon-ion and proton therapy, image-guided techniques, and stereotactic body radiation therapy (SBRT). He is committed to integrating novel immuno-radiotherapy approaches into practice and advancing care through research and education.

Dr. Ebner also leads efforts in artificial intelligence and computational modeling to improve cancer care. His work emphasizes accuracy, transparency, and equity while helping care teams provide meaningful support to patients through digital tools and predictive modeling.

Areas of expertise

Dr. Ebner offers highly specialized expertise in radiation oncology with a focus on advanced treatment technologies:

• Head and neck cancer: Comprehensive radiation therapy strategies for complex tumors
• Carbon-ion and proton therapy: Precision-based therapies for challenging and recurrent cancers
• Image-guided radiation therapy: Techniques to improve targeting accuracy while reducing side effects
• Stereotactic body radiation therapy (SBRT): Non-invasive, high-dose radiation for localized tumors
• Immuno-radiotherapy approaches: Combining immunotherapy and radiation for synergistic cancer control
• Artificial intelligence in oncology: Computational tools for improved treatment planning and patient communication

Research and expertise

Dr. Ebner's academic work spans translational research and digital health innovation. He studies how artificial intelligence and computational modeling can enhance care delivery, improve clinical data quality, and bridge molecular biology with radiation response. His research focuses on responsible implementation of technology that prioritizes accuracy, transparency, and equity in cancer care.